INNOVATION PHARMACEUTICALS INC. Proceeds from Warrant Exercises
INNOVATION PHARMACEUTICALS INC. reported Proceeds from Warrant Exercises of $0 for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2023-09-28
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for the quarter ending 2022-09-30 was $4.98M.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for the quarter ending 2022-06-30 was $0.00.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for the quarter ending 2021-06-30 was -$5.02M, a 1360.55% decline year-over-year.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for fiscal 2022 was $4.98M.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- INNOVATION PHARMACEUTICALS INC. proceeds from warrant exercises for fiscal 2020 was $3.04M, a 11.31% increase from fiscal 2019.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month | Proceeds from Warrant Exercises 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-09-28 | ||||
| 2022-09-30 | $4.98M 10-Q · filed 2022-11-10 | $4.98M derived: sum of 2 quarters · filed 2023-09-28 | $4.98M derived: sum of 3 quarters · filed 2023-09-28 | ||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $0.00 derived: sum of 2 quarters · filed 2023-09-28 | $4.98M 10-K · filed 2023-09-28 | ||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $4.98M 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | $4.98M 10-Q · filed 2022-02-14 | ||||
| 2021-06-30 | -$5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 derived: sum of 3 quarters · filed 2022-11-10 | $0.00 10-K · filed 2021-09-27 | |
| 2021-03-31 | $5.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $5.02M derived: sum of 2 quarters · filed 2022-11-10 | $5.02M 10-Q · filed 2022-11-10 | $5.42M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 | $398.00K derived: sum of 3 quarters · filed 2022-02-14 | $1.89M derived: sum of 4 quarters · filed 2022-02-14 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | $398.00K derived: sum of 2 quarters · filed 2021-09-27 | $1.89M derived: sum of 3 quarters · filed 2021-09-27 | $2.01M derived: sum of 4 quarters · filed 2021-09-27 | |
| 2020-06-30 | $398.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | $1.89M derived: sum of 2 quarters · filed 2021-09-27 | $2.01M derived: sum of 3 quarters · filed 2021-09-27 | $3.04M 10-K · filed 2021-09-27 | $6.70M 10-K · filed 2020-09-14 |
| 2020-03-31 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $1.61M derived: sum of 2 quarters · filed 2021-05-13 | $2.64M 10-Q · filed 2021-05-13 | $4.12M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-22 | $1.15M 10-Q · filed 2021-02-22 | $2.63M derived: sum of 3 quarters · filed 2021-02-22 | $3.86M derived: sum of 4 quarters · filed 2021-02-22 | |
| 2019-09-30 | $1.03M 10-Q · filed 2020-11-16 | $2.50M derived: sum of 2 quarters · filed 2020-11-16 | $3.74M derived: sum of 3 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-14 | $2.71M derived: sum of 2 quarters · filed 2020-09-14 | $2.73M 10-K · filed 2020-09-14 | ||
| 2019-03-31 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14 | $1.25M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $20.00K 10-Q · filed 2019-02-08 | ||||
| 2014-12-31 | $11.20K 10-Q · filed 2015-02-09 |